MedPath

Zevas

Brand Name: Zevas

Generic Name: Rosuvastatin (as calcium) + Ezetimibe

Active
Registration Number

DR-XY48261

Dosage Form

Film-Coated Tablet

Issuance Date

August 5, 2022

Expiry Date

August 5, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 mg/10 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Lipid Modifying Agents
A
Application
Monitored Release
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Rosuvastatin (as calcium)Active
EzetimibeActive
Monograph: Ezetimibe

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform